Northwestern’s sponsored research awards grew to $702.1 million last fiscal year, the largest amount in the University’s history and a 3.8 percent increase over the previous year’s record-breaking $676.5 million.
In a study published in Nature, Northwestern Medicine scientists have demonstrated that a gene is critical for the development of the ear’s outer hair cells, which has important implications for hearing loss treatments.
A Northwestern Medicine study has demonstrated that an age-related increase in estrogen may be the culprit behind a common hernia in elderly men.
Linda Suleiman, MD, ’17 GME, assistant professor of Orthopaedic Surgery, discusses her recent study on the representation of women in orthopaedic surgery.
An experimental genetic inhibitor that could stave off Alzheimer’s disease has unintended consequences, but may represent a target for future drug development, according to a recent study.
Metformin, an inexpensive diabetes drug, has been found to reduce the risk of heart attacks and strokes triggered by air pollution by reducing inflammation in the lungs that triggers clotting.
An oral therapy called ibudilast significantly reduced the rate of brain tissue loss in patients with progressive multiple sclerosis, according to the results of a phase II trial.
Second-year medical students showcased ongoing results from their Area of Scholarly Concentration projects at a recent poster session.
Northwestern Medicine investigators are leading a Specialized Program of Research Excellence (SPORE) in brain cancer with a special emphasis on glioblastoma.
Scientists have developed soft materials that assemble and disassemble on demand, opening the door for applications including robotics, drug delivery and tissue regeneration.